Wells Fargo Maintains Merck & Co(MRK.US) With Hold Rating, Maintains Target Price $125
Merck & Co Analyst Ratings
Citic Securities Initiates Merck & Co. at Buy With $136 Price Target
A Quick Look at Today's Ratings for Eli Lilly and Co(LLY.US), With a Forecast Between $1,025 to $1,113
Eli Lilly & Co: Strategic Pricing and Market Expansion Fuel Buy Rating
Cantor Fitzgerald Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $155
Jefferies Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Raises Target Price to $670
Eli Lilly Analyst Ratings
Hold Rating on Abbott Laboratories Amid NEC Litigation Uncertainties
Jefferies Maintains Abbott Laboratories(ABT.US) With Hold Rating, Raises Target Price to $120
Evercore ISI Raises Price Target on AbbVie to $192 From $180, Keeps Outperform Rating
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
Eli Lilly & Co (LLY) Receives a Buy From Barclays
AbbVie Analyst Ratings
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344
Piper Sandler Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $209
Piper Sandler Sticks to Its Buy Rating for AbbVie (ABBV)
BTIG Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135
Abbott Laboratories Analyst Ratings
Citi Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $127